As part of its efforts to reach a global settlement to resolve opioid claims, Mallinckrodt will file for Chapter 11 bankruptcy for its specialty generics subsidiary.
Lachman Consultants has revealed more of the story behind the decline of the now bankrupt CRO Cetero/PRACS, which even though it’s shuttered, is still dealing with the fallout from its data integrity issues.
Pharmaceutical and healthcare carton specialists, Chesapeake has formed an alliance with carton supplier Cartonajes Leca in a move that aims to extend its production network to southern Europe.
After losing a key Novartis contract and getting caught up in the
Inyx collapse, Inventiv Health had good news this week when it
reported its third quarter results.
A US bankruptcy court judge ruled on Friday that Puerto Rican-based
pharma services firm Inyx USA be put under the control of an
independently-appointed trustee.
The latest twists and turns in the Inyx Inc. bankruptcy saga
include an attempted power seize by its creditor, fraud allegations
thrown around courtrooms and in the media, the resignation of Inyx'
accountants, and increasing...
AAIPharma is showing the first signs of life after bankruptcy,
buying its first company after emerging from the ordeal - a
French-based clinical research organisation (CRO).
India's Dishman Pharmaceuticals & Chemicals has snapped up the
Swiss-based pharmaceutical services business, Carbogen and Amcis,
of financially-troubled US chemical firm Solutia for the sum of
$74.5m (€58m).
The trials and tribulations affecting US generics maker Able
Laboratories took a decisive turn yesterday when the company filed
for Chapter 11 bankruptcy protection, reports Phil Taylor.
Solutia has drawn up an agreement with former parent Monsanto that
could finally bring it out of the state of bankruptcy
reorganisation it has resided in since the end of 2003, reports
Phil Taylor.
The troubles affecting the global chemicals industry were brought
into sharp focus today when Solutia filed for Chapter 11 bankruptcy
protection, citing onerous financial commitments to its former
parent Monsanto that are hampering...
